<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00990366</url>
  </required_header>
  <id_info>
    <org_study_id>58/180/2009</org_study_id>
    <nct_id>NCT00990366</nct_id>
  </id_info>
  <brief_title>Treatment of Biliary Obstruction Using Biliary Stent With or Without Antireflux Valve</brief_title>
  <official_title>Treatment of Biliary Obstruction Using Biliary Stent With or Without Antireflux Valve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biliary obstruction can be relieved by biliary stent. Ascending infection of biliary passage
      (cholangitis) causes hospitalization and obstruction of stents. Reflux of intestinal fluids
      through a stent is thought to be one of the causes of cholangitis. Stents with antireflux
      valves are designed to reduce the reflux from the bowel. The purpose of the study is to
      investigate prospectively whether it is possible to reduce the amount of infection and thus
      obstruction of biliary stent by using a stent with an antireflux valve compared to a normal
      stent without an antireflux valve.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Interim analysis results, study terminated 5/2010
  </why_stopped>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patency of a biliary stent</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cholangitis</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Biliary Obstruction</condition>
  <condition>Cholangitis</condition>
  <arm_group>
    <arm_group_label>biliary stent without an antireflux valve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients with biliary obstruction who need a biliary stent, selected for the stent without an antireflux valve arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>biliary stent with an antireflux valve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients with biliary obstruction, who need a biliary stent, selected for the stent with an antireflux valve arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CookÂ´s biliary stent with an antireflux stent, normal biliary stent</intervention_name>
    <description>arms are assigned randomly by closed envelope method</description>
    <arm_group_label>biliary stent without an antireflux valve</arm_group_label>
    <arm_group_label>biliary stent with an antireflux valve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-89

          -  biliary obstruction in the lower two thirds of the choledochus

        Exclusion Criteria:

          -  allergy to contrast media

          -  future pancreaticoduodenectomy

          -  refusal from the study

          -  previous stent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paulina Salminen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2009</study_first_submitted>
  <study_first_submitted_qc>October 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2009</study_first_posted>
  <last_update_submitted>October 10, 2011</last_update_submitted>
  <last_update_submitted_qc>October 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Hanna Vihervaara</investigator_full_name>
    <investigator_title>Ph.D.</investigator_title>
  </responsible_party>
  <keyword>antireflux valve</keyword>
  <keyword>biliary obstruction</keyword>
  <keyword>cholangitis</keyword>
  <keyword>biliary stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

